View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Malvern Panalytical
31 March 2020

Unlocking the Power of Expert Analytics

Malvern Panalytical, with Concept Life Sciences (Cheshire, UK), has begun an innovative partnership that unites advanced instrumentation with proficient analytical services for discovery and development.

This collaboration delivers the unique ability to develop and deploy accredited physicochemical analysis techniques and methods within the pharmaceutical and food industries, underpinned by Malvern Panalytical’s understanding of analytical instrumentation and Concept Life Sciences’ method validation and support expertise.

The initial focus of the partnership is the provision of targeted analytics support to industries operating in regulated sectors worldwide, such as pharmaceuticals, where collaborative working is increasingly critical to business success.   “Many pharmaceutical companies no longer have the deep analytical capabilities and expertise in-house that were once the norm,” said Dr Mark Carnegie-Brown, President of Concept Life Sciences. “However, they recognize the value of analytical data at key decision points in their development workflows; this enables the early elimination of non-viable formulations through better prediction of properties and performance. As a result, these companies are seeking partners who can help accelerate and support their development pipelines. Our collaboration with Malvern Panalytical unites our respective analytical know-how to fulfil this requirement.”

Steven Horder, VP Business Sectors, Malvern Panalytical, said: “Malvern Panalytical and Concept Life Sciences are experts in understanding the needs of customers and in deploying appropriate analytical solutions. We have worked together in the past as two Spectris operating companies, and this closer relationship opens new opportunities which will add even greater value to our customers’ processes. Our combined experience enables us to provide analytical solutions that deliver the insightful data our customers require for informed decision-making.”

Constraints on both laboratory resources and also access to relevant expertise are recognized as impacting the ability of organizations to generate the data they need to understand, control and optimize new products and processes. While the partnership between Malvern Panalytical and Concept Life Sciences will initially focus on the combination of contract services and analytical instrumentation, future developments are expected to deliver enhanced solutions in key areas of product development. Steven Horder added: “With the increasing use of big data in the pharmaceutical, agrochemical and food industries and beyond, and the trend across manufacturing to access specialist skills through partnerships, we see a growing need and opportunity to develop an even broader offering that will help turbocharge development pipelines.”

For more information, please fill out the enquiry form attached to this page.

The purpose of this document is to describe how PANalytical systems support system owners meeting the requirements of the 21 CFR Part 11 regulations issued...
The age of the battery is well underway. Lithium-ion batteries, for example, have already revolutionized our day-to-day lives – from smart mobile devices to pollution-free...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena